Pain Management and Addiction: Clinical Challenges

Similar documents
Pain and Safe Prescribing

SUBSTANCE ABUSE PATIENT

Improving Safety in Opioid Prescribing: A Framework for Chronic Pain in Outpatient Practice

The Challenging Patient with Chronic Opioid Usage MD ACP Meeting

OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse

2014 MA ACP Annual Scientific Meeting 1

Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain

Assessing and Screening for Addiction in Chronic Pain Patients

Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R)

Appendix F Federation of State Medical Boards

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998

INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine

Medication Use & Chronic Pain Control: Managing Tolerance, Dependence, Addiction & Aberrant Medication Taking Behavior

Colorado State Board of Medical Examiners Policy

Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic

ASPMN Conference Baltimore, Maryland

Practical Pain Assessment- Screening for Psychosocial Risk. Session #3 Roman D. Jovey, MD

Disclosures. Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Disclosures. The Problem. The Problem. The Problem. The Problem. Buprenorphine Use in Combined Chronic Pain and Opioid Addiction

Medication Misuse and Abuse: A Growing Epidemic

MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent

Patient Application for Treatment

Nurse Practitioner Practice Guideline Treatment Agreements

Opioids: Use and Misuse/Steven Feinberg, MD; Scott Levy, MD, MPH, FACOEM

Rule Governing the Prescribing of Opioids for Pain

Reference for Physicians on the Use of Opioid Analgesics in the Treatment of Chronic Pain, in the Office Setting

Proper Use of Prescription Stimulant Medication

Proposed Revision to Med (i)

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

MEDICATION MANAGEMENT AGREEMENT

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx

RED FLAGS, SCREENING AND DIAGNOSING OUD IN CHRONIC PAIN PATIENTS DR. PAULA COOK & DR. ELIZABETH HOWELL

Use of Opioids for Chronic Non Malignant Pain (CNMP)

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018

Minimizing Misuse of Opioids in Chronic Pain

Prevalence and Etiology of the Non-Medical Use of Prescription Medications among College Students

The Difficult Patient: Risk Mitigation Strategies

Readopt with amendment Med 502, effective (Document #11090), to read as follows:

Opioids in the Management of Chronic Pain: An Overview

ADDRESSING PRESCRIPTION PAIN MEDICINE ABUSE & MISUSE: A FRAMEWORK FORSAFE PRESCRIBING

The dog ate my methadone: Challenges in treating patients with advanced illness, pain, and addiction

WHAT YOU NEED TO KNOW TO ABOUT AB 474

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

Methadone Maintenance 101

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Chronic Pain, Opioids, & Addiction: Assessing and Managing Risk

Clinical studies of abuse deterrent opioid analgesics: Definitions, current approaches, and critical issues

Screening Patients for Substance Use in Your Practice Setting

Risk Reduction Strategies in Pain Management

Opiate Use Disorder and Opiate Overdose

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina

Teaching Objectives Describe the balance a that must be sought in the treatment of pain and the prevention of drug diversion. Discuss regulatory polic

Substance Use Disorders

Prescription Opioid Addiction

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

2/28/2017. Biography. Disclosure. Falling Down the Rabbit Hole: A Primer for Chronic Pain Management & Comorbid Substance Use Disorders

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Opioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016

Buprenorphine & Controlled Substance Treatment Agreement

Controlled Substance and Wellness Agreement

Pain, Opioids, & Substance Use Disorders

Opioids and Chronic Pain

PATIENT HISTORY DATA FORM Psychiatric, Health and Wellness, LLC 810 Michael Drive, Suite L Chesterton, IN NAME

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

Chronic Pain Management in the Primary Care Setting

Addiction and the Brain. Addiction: The 5 C s. Facts About Addiction 8/7/2017. Opioid Addiction: Addressing the Epidemic NEUROBIOLOGY OF ADDICTION

Opioid dependence and buprenorphine treatment

John Murphy DO, MS Lynx Healthcare

Patient Agreement for the use of Opioid Medications

Ahsan U. Rashid, M.D., F.A.C.P.

Opioid Therapy, Pain, and Addiction at the Crossroads

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

Based on Tip 54. Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders KAP KEYS FOR CLINICIANS

9/12/2012 ALCOHOL AND DRUG USE, ASSOCIATED DISORDERS AND THEIR PSYCHIATRIC COMORBIDITIES IN U.S. ADULTS OBJECTIVES

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Brief Pain Inventory (Short Form)

Best Practices for Prescribing Controlled Substances

Opioid Management of Chronic (Non- Cancer) Pain

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM

Prescription Drug Abuse National Perspective

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

Medication Management

Year

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing

Chronic Disease Management for Pain: It CAN be done in primary care!

Addicted, Alone, Forgotten, and Ashamed

The Role of the PDMP: Foundational Knowledge and Best Practices

Classification of Abuse-Related Events in Analgesic Clinical Trials: Recommendations and Research Agenda

An Internist s Guide to Unhealthy Alcohol Use. Ryan Graddy, MD JHU SOM

For female patients only: To the best of my knowledgei am NOT pregnant. Patients Initials:

Patient-reported and interview-rated abuse-related outcomes

Evidence of Co-occurring Alcohol and Prescription Opioid Abuse in Clinical Populations: Implications for Screening

Evaluating Abuse, Misuse, Diversion, Overdose, Addiction, and Death in the Patient Population

Chapter 23. Medicines and Drugs

Transcription:

Pain Management and Addiction: Clinical Challenges MMS Pain Management Forum March 12, 2010 Associate Professor of Medicine Boston University School of Medicine Boston Medical Center Conflicts of Interest Disclosure None Pain Management & Addiction Outline The issues The risk of addiction Diagnosing addiction Treating patients with addiction Boston University School of Medicine 1

The Issues Exhibit 2: Past Year Initiation of Non-Medical Use of Prescription-type Psychopharmaceutics, Age 12 or Older: In Thousands, 1965 to 2005 1 3000 2500 New Users (x 1000) 2000 1500 1000 500 0 1965 1967 1969 1971 1973 1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 Analgesics Tranquilizers Stimulants Sedatives Source: SAMHSA, OAS, NSDUH data, July 2007 Boston University School of Medicine 2

Opioids & the Brain Behavior Euphoria Physical Dependence Pain May Reduce Addiction Risk Patients on morphine with successful nerve block developed CNS depression Less physical dependence Less opioid reward or euphoria Brown et al., 2002, Vaccarino et al., 1993, Zacny et al., 1996 Unintentional Opioid Overdoses & Annual Prescription Opioid Sales 1990-2006 Crude rate per 100,000 8 7 6 5 4 3 2 1 0 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 600 500 400 300 200 100 0 Sales in mg/person Deaths per 100,000 Opioid sales (mg per person) Source: Paulozzi, CDC, Congressional testimony, 2007 National Vital Statistics System Boston University School of Medicine 3

Opiophobia Issues Preventing Opioid Prescribing Potential for patients to become addicted Potential for patients to sell or divert Opioid side effects Regulatory/law enforcement monitoring Hassle and time required to track/refill 89% 75% 53% 40% 28% Upshur CC et al. J Gen Intern Med 2006 The Challenge. Opioid Addiction Prescription Drug Misuse Aberrant Medication Taking Behaviors (AMTBs) A spectrum of patient behaviors that may reflect misuse Total Chronic Pain Population Boston University School of Medicine 4

The Risk of Addiction Published rates of abuse and/or addiction in chronic pain populations are 3-19% Known risk factors for addiction to any substance are good predictors for problematic prescription opioid use Past cocaine use, h/o alcohol or cannabis use 1 Lifetime history of substance use disorder 2 Family history of substance abuse, a history of legal problems and drug and alcohol abuse 3 Tobacco dependence 4 History of severe depression or anxiety 4 1 Ives T et al. BMC Health Services Research 2006 2 Reid MC et al JGIM 2002 3 Michna E el al. JPSM 2004 4 Akbik H et al. JPSM 2006 Detection of Substance Abuse in Primary Care Among patients presenting for addiction treatment who had a primary care physician (n=1440), 45% stated their physician was unaware of their substance abuse Saitz R et al. Am J Drug Alcohol Abuse. 1997 Screening for Substance Abuse Risky alcohol use How many times in the past year have you had 5* or more drinks in a day? (positive answer: > 0) * (*4 for women or men >65) Prescription and illicit drug misuse/abuse How many times in the past year have you used an illegal drug or used a prescription medication for non-medical reasons? (positive answer: > NIAAA. Clinicians Guide to Helping Patients Who Drink Too Much, 2007. Smith PC, et al. Alcohol Clin Exp Res 2007; 22(Suppl 1):108. Boston University School of Medicine 5

Screener & Opioid Assessment for Pts w/ Pain (SOAPP -SF) Evaluate for relative risk for developing problems: 86% sensitive, 67% specific 0=Never, 1=Seldom, 2=Sometimes, 3=Often, 4=Very often 1. How often do you have mood swings? 2. How often do you smoke a cigarette within an hour after you wake up? 3. How often have you taken medication other than the way it was prescribed? 4. How often have you used illegal drugs (for example, marijuana, cocaine, etc) in the past 5 years? 5. How often, in your lifetime, have you had legal problems or been arrested? > 4 is POSITIVE < 4 is NEGATIVE 2008 Inflexxion, Inc. Diagnosing Addiction Making the Diagnosis Diagnosing Opioid Dependence in Patients on Chronic Opioids is Difficult Requires 3 or more criteria occurring over 12 months 1. Tolerance YES 2. Withdrawal/Physical dependence YES 3. Taken in larger amounts or over longer period - MAYBE 4. Unsuccessful efforts to cut down or control - MAYBE 5. Great deal of time spent to obtain substance - MAYBE 6. Important activities given up or reduced - MAYBE 7. Continued use despite harm - MAYBE American Psychiatric Association DSM IV-TR 2000 Boston University School of Medicine 6

Addiction is A primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations A clinical syndrome presenting as Loss of Control Aberrant Compulsive use Medication Continued use despite harm Taking Craving Behaviors Savage SR et al. J Pain Symptom Manage 2003 Aberrant Medication Taking Behavior A spectrum of patient behaviors that may reflect misuse: Health care use patterns (e.g., inconsistent appointment patterns) Signs/symptoms of drug misuse (e.g., intoxication) Lying and illicit drug use Problematic medication behavior (e.g., noncompliance) Implications Concern comes from the pattern or the severity Butler et al. Pain. 2007 Aberrant Medication Taking Behavior Less Likely to be Predictive of Addiction Yellow Flags Complaints about need for more medication Drug hoarding Requesting specific pain medications Openly acquiring similar medications from other providers Occasional unsanctioned dose escalation Nonadherence to other recommendations for pain therapy Passik SD Mayo Clin Proc 2009 Boston University School of Medicine 7

Aberrant Medication Taking Behavior More Likely to be Predictive of Addiction Red Flags Deterioration in functioning at work or socially Illegal activities-selling, forging, buying from nonmedical sources Injection or snorting medication Multiple episodes of lost or stolen scripts Resistance to change therapy despite adverse effects Refusal to comply with random drug screens Concurrent abuse of alcohol of illicit drugs Use of multiple physicians and pharmacies Passik SD Mayo Clin Proc 2009 What Does Addiction Look Like? No evidence of addiction Evidence of addiction Control over medication use Improved quality of life Aware & dislikes side effects Concern about medical problems Adheres to treatment plan Concern pain relief > opioid No control over medication Worsened quality of life Requests dose increase despite side effects Lack of concern about medical problems Non-adherent to treatment plan Concern opioid > pain relief Monitoring for Misuse Universal Precautions Agreements/contracts Monitor for aberrant medication taking behavior Monitor for adherence, addiction and diversion Urine drug testing Pill counts 28 day supply Initially small quantities & frequent visits Establish a refill & cross coverage system Prescription monitoring program data FSMB Guidelines 2004 www.fsmb.org Gourlay DL, Heit HA. Pain Medicine 2005 Chou R et al. J Pain 2009 Boston University School of Medicine 8

Discussing Monitoring Discuss risks of opioid medications Discuss agreements, pill counts, drug tests, etc. as ways to protect patient from harm Statin - LFTs monitoring analogy Use consistent approach, but set level of monitoring to match risk Urine Drug Tests Evidence of therapeutic adherence Evidence of non-use of illicit drugs Know limitations of test and your lab Know a toxicologist/clinical pathologist Complex patient-physician communication Gourlay DL, Heit HA, Caplan YH. Urine drug testing in primary care. Dispelling myths and designing strategies monograph (www.familydocs.org/files/udtmonograph.pdf) Urine Toxicology Monitoring in Patients on Opioids for Chronic Pain BEHAVIOR ISSUES YES NO TOTAL URINE TOX POSITIVE 10 (8%) 26 (21%) 36 (29%) NEGATIVE 17 (14%) 69 (57%) 86 (71%) TOTAL 27 (22%) 95 (78%) 122 26/122 (21%) of patients had no aberrant behavioral issues BUT had abnormal drug test Katz NP et al. Clinical J of Pain 2002 Boston University School of Medicine 9

Opioid Risk Monitoring: COMM Current Opioid Misuse Measure Patient self-administered validated questionnaire 17 items, takes ~10 minutes Helps for deciding on level of monitoring It is NOT a lie detector Key elements: over-sedation, consequences of overuse, multiple prescribers, medication misuse, active mental health issues, compulsive use, obtaining meds from someone else, loss of control 2008 Inflexxion, Inc. Exit Strategy Discussing Possible Addiction Explain observed aberrant behaviors raises your concern for possible addiction. Benefits no longer outweighing risks. I cannot responsibly continue prescribing opioids as I feel it would cause you more harm than good. Always offer referral to substance abuse treatment. Stay 100% in Benefit/Risk of Med mindset. Treating Patients with Addiction Boston University School of Medicine 10

Undertreatment of Pain 516 ambulatory AIDS patients with chronic pain Patients who reported injection-drug use (IDU) as their HIV risk factor were significantly more likely to be under-medicated Opioid analgesia was withheld from all patients with IDU history, regardless of whether current users, drug-free or in a methadone maintenance program Breitbart W et al. Pain. 1997 Managing Pain in Patients with History of Addiction Complicated by: Generalized opiophobia Regulatory scrutiny and uncertainty about laws and regulations governing use of opioids Prevailing moral and social (punitive) views of addiction Clinician concerns regarding causing or contributing to addiction or being duped 2004 FSMB Model Policy Use of Controlled Substances for the Treatment of Pain Physicians should not fear disciplinary action from the Board for prescribing opioid analgesics, for a legitimate medical purpose Compliance with state or federal law is required. Management of pain in patients with a h/o substance abuse may require extra care, monitoring, documentation and consultation with or referral to an expert in the management of such patients. Boston University School of Medicine 11

Potential Risks of Prescribing Prescribed opioid analgesic may serve as a trigger for relapse - cross-addiction Difficulty controlling use Patient may be pressured to supply opioids to addicted friends Patient may be tempted to sell opioids to supplement personal (disability) income Potential Risks of Not Prescribing Continued addiction-self medicating pain with alcohol and/or illicit drugs Unsuccessful detoxification because untreated pain worsens during withdrawal Increased distress and anxiety may trigger relapse to active alcohol or drug use Active Drug Use Results in a Syndrome of Pain Facilitation Pain experience is augmented by: Subtle withdrawal syndromes Intoxication and withdrawal-related sympathetic arousal, muscular tension Sleep disturbance Affective changes Functional changes Savage and Schofferman, 1995 Boston University School of Medicine 12

Addiction alters Pain Experience Both stimulant and opioid abusers have less pain tolerance than peers in remission or matched controls Former opioid abusers have decreased pain tolerance to pain compared with non-addict siblings HIV-infected patients w/ hx of substance abuse required higher doses of opioid analgesics than patients without a hx of substance abuse Therefore, patients with a history of addiction may be more pain sensitive and require higher opioid doses Martin J (1965), Ho and Dole V (1979), Compton P (1994, 2001), Swica Y (2002) Born with decreased pain tolerance and therefore higher risk of developing opioid addiction History of opioid addiction altered nervous system resulting in lower pain tolerance Summary Increased availability of opioid analgesics mirrors increased reports of misuse Patients with chronic pain should be assessed for risk of opioid misuse Predicting and diagnosing addiction in patients with chronic pain can be challenging, therefore monitor using universal precautions Treating patients with a history of, or active, addiction is complicated and may require consultation, if available Boston University School of Medicine 13